Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock

Clinical trial NCT02191475 · UNKNOWN

Trial details

NCT number: NCT02191475
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Abdominal Infection

Start date: 2014-05-01
Primary completion: 2017-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.